Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Composition of Blood Plasma01:24

Composition of Blood Plasma

7.6K
Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins,...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GMP in donor centres.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Considerations on the number of plasma donations per donor per year: Pro.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Challenges for Plasma-Derived Medicinal Products.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same author

Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same author

COVID 19 convalescent plasma: Is there still a place for CCP?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2023
Same author

Reply to the Letter-to-the-Editor Comment to Moog et al.: Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023

Related Experiment Video

Updated: Jan 3, 2026

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
07:37

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells

Published on: November 17, 2017

13.3K

The plasma supply in Germany.

Rainer Moog

    Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
    |November 23, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Germany

    Keywords:
    Coagulation factorsImmunoglobulinPlasma for fractionationPlasma supplyTherapeutic plasma

    More Related Videos

    A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
    11:36

    A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood

    Published on: April 28, 2016

    9.7K
    Treating Surfaces with a Cold Atmospheric Pressure Plasma using the COST-Jet
    06:36

    Treating Surfaces with a Cold Atmospheric Pressure Plasma using the COST-Jet

    Published on: November 2, 2020

    4.5K

    Related Experiment Videos

    Last Updated: Jan 3, 2026

    Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
    07:37

    Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells

    Published on: November 17, 2017

    13.3K
    A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
    11:36

    A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood

    Published on: April 28, 2016

    9.7K
    Treating Surfaces with a Cold Atmospheric Pressure Plasma using the COST-Jet
    06:36

    Treating Surfaces with a Cold Atmospheric Pressure Plasma using the COST-Jet

    Published on: November 2, 2020

    4.5K

    Area of Science:

    • Medical Sciences
    • Public Health
    • Biotechnology

    Background:

    • Germany aims for self-sufficiency in plasma supply.
    • Previous efforts have been made to meet this demand.
    • This report details the current state of plasma supply in Germany.

    Purpose of the Study:

    • To analyze the current status of plasma collection and utilization in Germany.
    • To assess trends in therapeutic plasma and source plasma for fractionation.
    • To evaluate the supply chain of plasma derivatives.

    Main Methods:

    • Data collection from the Paul-Ehrlich-Institute.
    • Analysis of data on blood and plasma collection and use.
    • Review of import/export data for plasma derivatives.

    Main Results:

    • Therapeutic plasma collection declined slightly but peaked in 2017.
    • Plasma for fractionation remained stable at approximately 2 million liters annually.
    • Immunoglobulin manufacturing increased, while Factor VIII and IX use persists.
    • Import/export activities ensure plasma derivative availability.
    • Fibrinogen supplementation and patient blood management reduced therapeutic plasma use.

    Conclusions:

    • Germany's plasma supply chain is complex, involving domestic collection and international trade.
    • Increased immunoglobulin production addresses rising demand for treating immunodeficiencies.
    • Despite recombinant alternatives, plasma-derived Factor VIII and IX remain relevant.
    • Optimized clinical practices can reduce therapeutic plasma consumption.